Wu, XiaokeYu, KaijiangWang, YongchenXu, WanhaiMa, HongliHou, YanLi, YueCai, BenzhiZhu, LiyingZhang, MinHu, XiaoliGao, JingshuWang, YuQin, HuichaoWang, WenjieZhao, MingyanWu, XiaZhang, YongLi, LuLi, KangDu, ZhiminMol, Ben Willem JYang, Baofeng2021-04-022021-04-022020-10Wu, X, Yu, K, Wang, Y, Xu, W, Ma, H, Hou, Y, Li, Y, Cai, B, Zhu, L, Zhang, M, Hu, X, Gao, J, Wang, Y, Qin, H, Wang, W, Zhao, M, Wu, X, Zhang, Y, Li, L, Li, K, Du, Z, Mol, B W J & Yang, B 2020, 'Efficacy and safety of triazavirin therapy for coronavirus disease 2019 : A pilot randomized controlled trial', Engineering (Beijing, China), vol. 6, no. 10, pp. 1185-1191. https://doi.org/10.1016/j.eng.2020.08.0112095-8099PubMedCentral: PMC7476906https://hdl.handle.net/2164/16182Acknowledgements: We are deeply grateful to the front-line clinicians who participated in the study while directly fighting the epidemic. This study was supported by the Chinese Academy of Engineering Projects for COVID-19 (2020-KYGG-01-04) and Heilongjiang Province Urgent Project-6 for COVID-19. Data and safety monitoring board members of this trial included Kang Li, Yong Zhang, Songjiang Liu, and Yaohui Shi.7709031engCoronavirus disease 2019TriazavirinEfficacySafetyR MedicineGeneral EngineeringEnergy Engineering and Power TechnologyGeneral Chemical EngineeringGeneral Computer ScienceEnvironmental EngineeringMaterials Science (miscellaneous)RJournal article10.1016/j.eng.2020.08.011http://www.scopus.com/inward/record.url?scp=85091712049&partnerID=8YFLogxK610